Bronchopulmonary Dysplasia
📧 Sign up to get email alerts when something new happens for Bronchopulmonary Dysplasia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-03-15Clinical Trial Update: Effects of Fat-soluble Vitamins Supplementation on Common Complications and Neural Development in Very Low Birth Weight Infants [Phase 3]
Phase 3 trial evaluating fat-soluble vitamin supplementation effects on complications and neural development in very low birth weight infant…
-
CLINICAL_TRIALS trial_result · 2019-03-06Clinical Trial Update: Human Mesenchymal Stem Cells For Infants At High Risk For Bronchopulmonary Dysplasia [Phase 1, Phase 2]
Clinical trial evaluating human mesenchymal stem cells in infants at high risk for bronchopulmonary dysplasia (Phases 1/2).
-
CLINICAL_TRIALS trial_result · 2019-01-15Clinical Trial Update: Human Mesenchymal Stem Cells For Moderate and Severe Bronchopulmonary Dysplasia [Phase 2]
Phase 2 clinical trial update evaluating human mesenchymal stem cells for moderate to severe bronchopulmonary dysplasia (BPD).
-
CLINICAL_TRIALS trial_result · 2018-11-15Clinical Trial Update: Duration of Continuous Positive Airway Pressure and Pulmonary Function Testing in Preterm Infants [NA]
A completed clinical trial investigating duration of continuous positive airway pressure and pulmonary function testing in preterm infants w…
-
CLINICAL_TRIALS trial_result · 2018-10-02Clinical Trial Update: PREMILOC Trial to Prevent Bronchopulmonary Dysplasia in Very Preterm Neonates [Phase 3]
Phase 3 trial PREMILOC aimed to prevent bronchopulmonary dysplasia in very preterm neonates has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-08-16Clinical Trial Update: Safety and Efficacy of PNEUMOSTEM® in Premature Infants at High Risk for Bronchopulmonary Dysplasia (BPD) - a US Study [Phase 1, Phase 2]
Phase 1/2 trial update on safety and efficacy of PNEUMOSTEM in premature infants at high risk for bronchopulmonary dysplasia.
-
CLINICAL_TRIALS trial_result · 2018-06-27Clinical Trial Update: Trial II of Lung Protection With Azithromycin in the Preterm Infant [Phase 2]
A Phase 2 trial update reporting results of azithromycin for lung protection in preterm infants at risk of bronchopulmonary dysplasia.
-
CLINICAL_TRIALS trial_result · 2018-06-27Clinical Trial Update: IntellO2 vs Manual Control for Optimizing Oxygenation in Infants [NA]
A completed clinical trial comparing the IntellO2 oxygen titration system to manual control for optimizing oxygenation in preterm infants wi…
-
CLINICAL_TRIALS trial_result · 2018-04-20Clinical Trial Update: Inhaled Corticosteroids for Treatment of Bronchopulmonary Dysplasia [NA]
A completed clinical trial investigating inhaled corticosteroids as a treatment for bronchopulmonary dysplasia.
-
CLINICAL_TRIALS trial_result · 2018-04-02Clinical Trial Update: Azithromycin in the Prevention of Lung Injury in Premature Newborn [Phase 4]
A Phase 4 trial evaluating azithromycin for the prevention of lung injury, specifically bronchopulmonary dysplasia, in premature newborns ha…
-
CLINICAL_TRIALS trial_result · 2017-11-06Clinical Trial Update: Post-hospitalization Nursing Effectiveness (PHONE) Study [Phase 3]
Phase 3 trial update for the PHONE study evaluating nursing effectiveness after hospitalization in infants with bronchopulmonary dysplasia. …
-
CLINICAL_TRIALS trial_result · 2017-09-26Clinical Trial Update: Vitamin A Supplementation for Extremely-Low-Birth-Weight Infants [Phase 1, Phase 2]
Clinical trial update on vitamin A supplementation in extremely low birth weight infants across Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2017-09-26Clinical Trial Update: Delivery Room CPAP in Extremely Low Birth Weight Infants [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating delivery room CPAP use in extremely low birth weight infants has completed enrollment and is advancing…
-
CLINICAL_TRIALS trial_result · 2017-07-19Clinical Trial Update: Study of Inhaled Nitric Oxide (iNO) and Respiratory Outcomes in Late Preterm Infants [Phase 2, Phase 3]
A Phase 2/3 trial evaluating inhaled nitric oxide for bronchopulmonary dysplasia in late preterm infants was terminated. Results have been p…
-
CLINICAL_TRIALS trial_result · 2017-06-20Clinical Trial Update: Single-Dose Intravenous Inositol Pharmacokinetics in Preterm Infants [Phase 2]
Phase 2 trial update reporting the pharmacokinetics of a single intravenous dose of inositol in preterm infants; study has completed.
-
CLINICAL_TRIALS trial_result · 2017-05-23Clinical Trial Update: Examining the Use of Non-Invasive Inhaled Nitric Oxide to Reduce Chronic Lung Disease in Premature Newborns [Phase 2]
A Phase 2 trial evaluating non-invasive inhaled nitric oxide to reduce bronchopulmonary dysplasia in premature newborns has completed and re…
-
CLINICAL_TRIALS trial_result · 2017-03-15Clinical Trial Update: Assessment of Lung Aeration at Birth [NA]
The clinical trial evaluating lung aeration at birth (NCT01739114) sponsored by the University of Alberta has completed, in relation to Bron…
-
CLINICAL_TRIALS trial_result · 2016-07-06Clinical Trial Update: Efficacy and Safety of Inhaled Budesonide in Very Preterm Infants at Risk for Bronchopulmonary Dysplasia [Phase 3]
Phase 3 clinical trial update on the efficacy and safety of inhaled budesonide in very preterm infants at risk for bronchopulmonary dysplasi…
-
CLINICAL_TRIALS trial_result · 2016-06-28Clinical Trial Update: Trial of Late Surfactant to Prevent BPD: A Pilot Study in Ventilated Preterm Neonates Receiving Inhaled Nitric Oxide [Phase 3]
Phase 3 trial evaluating late surfactant to prevent bronchopulmonary dysplasia in ventilated preterm neonates receiving inhaled nitric oxide…
-
CLINICAL_TRIALS trial_result · 2016-05-13Clinical Trial Update: Prolonged Outcomes After Nitric Oxide (PrONOx)
A completed clinical trial (PrONOx) investigates prolonged outcomes after inhaled nitric oxide in infants at risk for bronchopulmonary dyspl…
-
CLINICAL_TRIALS trial_result · 2016-05-10Clinical Trial Update: Prospective Study on Plasma Pro-endothelin-1 in Predicting Bronchopulmonary Dysplasia
A completed prospective clinical trial evaluating plasma pro-endothelin-1 as a predictor of Bronchopulmonary Dysplasia.
-
CLINICAL_TRIALS trial_result · 2016-04-14Clinical Trial Update: Seattle-PAP Bubble Nasal CPAP and Work of Breathing [Phase 1]
Phase 1 trial update of Seattle-PAP Bubble Nasal CPAP assessing work of breathing in premature infants; the study covered respiratory distre…
-
CLINICAL_TRIALS trial_result · 2016-02-18Clinical Trial Update: Developmental Sequelae of Severe Chronic Lung Disorders
This clinical trial update notes the completion of a study evaluating developmental sequelae in individuals with severe chronic lung disorde…
-
CLINICAL_TRIALS trial_result · 2016-02-18Clinical Trial Update: Inhaled Beclomethasone to Prevent Chronic Lung Disease [Phase 3]
A Phase 3 NHLBI-sponsored trial of inhaled beclomethasone to prevent chronic lung disease in preterm infants has completed.
-
CLINICAL_TRIALS trial_result · 2016-02-18Clinical Trial Update: Premature Birth and Its Sequelae in Women
This completed NHLBI-sponsored clinical trial investigated premature birth and its sequelae in women, with conditions including bronchopulmo…